K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease

K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Children With Chronic Kidney Disease

Barriers to successful care for chronic kidney disease

BACKGROUND The National Kidney Foundation has formulated clinical practice guidelines for patients with chronic kidney disease (K/DOQI). However, little is know about how many patients actually achieve these goals in a dedicated clinic for chronic kidney disease. METHODS We performed a cross-sectional analysis of 198 patients with an estimated glomerular filtration rate of less than 30 ml/min...

Dyslipidemias in chronic kidney disease: Current guidelines and future perspectives

Introduction Dyslipidemia is a major problem in chronic kidney disease (CKD) and haemodialysis patients. Although there has been much progress and reduction in the prevalence of dyslipidemia after the Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel), there were few specifi...

Survival benefit with regional anticoagulation with citrate in CRRT: the end of a myth?

of K/DOQI targets of mineral metabolism in Canada. Nephrol Dial Transplant 2011; 26: 156–163 6. Block GA, Zaun D, Smits G et al. Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients. Kidney Int 2010; 78: 578–589 7. Vervloet M, Bencova V, Malberti F et al. “Real-world” use of cinacalcet for managing SHPT in dif...

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Increasing evidence, accrued in the past decades, indicates that the adverse outcomes of chronic kidney disease, such as kidney failure, cardiovascular disease, and premature death, can be prevented or delayed. Earlier stages of chronic kidney disease can be detected through laboratory testing. Treatment of earlier stages of chronic kidney disease is effective in slowing the progression toward ...